Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Schizophrenia Research

• Publication date

  2013-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2013.04.027PMID 23706415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

  2013cited by this paper
• A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians.

  2011cited by this paper
• The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition.

  2010cited by this paper
• Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome.

  2010cited by this paper
• Impaired modulation of attention and emotion in schizophrenia.

  2010cited by this paper
• Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators.

  2010cited by this paper
• The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia.

  2010cited by this paper
• Cognitive-behavioral therapy for individuals at high risk of developing psychosis.

  2009cited by this paper
• Cognitive behavior therapy for psychosis: where have we been and where are we going?

  2009cited by this paper
• A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.

  2009cited by this paper
• Schizophrenia, "just the facts" 4. Clinical features and conceptualization.

  2009cited by this paper
• Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

  2009influential reference
• Abbreviated neuropsychological assessment in schizophrenia: Prediction of different aspects of outcome

  2009cited by this paper
• Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.

  2009cited by this paper
• Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers

  2008cited by this paper
• 1-year follow-up study of cognitive function in first-episode non-affective psychosis.

  2008cited by this paper
• Neuropsychological performance predicts clinical recovery in bipolar patients.

  2008cited by this paper
• Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

  2008influential reference
• A new rating scale for negative symptoms: the Motor-Affective-Social Scale.

  2008influential reference
• Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia

  2008cited by this paper
• Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.

  2008cited by this paper
• Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.

  2008cited by this paper
• Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS).

  2008cited by this paper
• Schizoaffective disorder: diagnostic issues and future recommendations.

  2008cited by this paper
• Predictors of medication competence in schizophrenia patients.

  2008cited by this paper
• Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.

  2008cited by this paper
• Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?

  2008cited by this paper
• General and specific cognitive deficits in schizophrenia: Goliath defeats David?

  2008cited by this paper
• [On bipolar disorder].

  2008cited by this paper
• A two-factor structure for the Schedule for the Deficit Syndrome in schizophrenia.

  2008influential reference
• Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.

  2007cited by this paper
• Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.

  2007influential reference
• Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia.

  2007cited by this paper
• Brief Assessment of Cognition in Schizophrenia: Validation of the Japanese version

  2007cited by this paper
• Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?

  2007cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007cited by this paper
• Neuropsychological functioning in bipolar disorder and schizophrenia.

  2007influential reference
• Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder.

  2007cited by this paper
• Neuropsychological symptom dimensions in bipolar disorder and schizophrenia.

  2007cited by this paper
• Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome.

  2007cited by this paper
• The genetic deconstruction of psychosis.

  2007cited by this paper
• Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients

  2007cited by this paper
• Emotion dysregulation in schizophrenia: reduced amplification of emotional expression is associated with emotional blunting.

  2007cited by this paper
• The NIMH-MATRICS consensus statement on negative symptoms.

  2006cited by this paper
• The factorial structure of the schedule for the deficit syndrome in schizophrenia.

  2006influential reference
• Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures.

  2006influential reference
• Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.

  2006cited by this paper
• Drug initiatives to improve cognitive function.

  2006cited by this paper
• Brain activity during emotionally negative pictures in schizophrenia with and without flat affect: an fMRI study.

  2005cited by this paper
• Early insight predicts depression and attempted suicide after 4 years in first‐episode schizophrenia and schizophreniform disorder

  2005cited by this paper
• Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia.

  2005cited by this paper
• Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review.

  2005cited by this paper
• Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

  2004cited by this paper
• Context-processing deficits in schizotypal personality disorder.

  2004cited by this paper
• Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.

  2004cited by this paper
• Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

  2004cited by this paper
• A brief cognitive assessment for use with schizophrenia patients in community clinics.

  2004cited by this paper
• Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

  2004cited by this paper
• Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.

  2004cited by this paper
• Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

  2004cited by this paper
• The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

  2004cited by this paper
• Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.

  2003influential reference
• Olfaction and social drive in schizophrenia.

  2003cited by this paper
• Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia.

  2003cited by this paper
• Cognitive impairments associated with formal thought disorder in people with schizophrenia.

  2002cited by this paper
• Dementia praecox and paraphrenia

  2002cited by this paper
• Negative symptoms in first episode non‐affective psychosis

  2002influential reference
• Negative symptoms of schizophrenia and compliance with medication.

  2001cited by this paper
• How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment.

  2001cited by this paper
• The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia.

  2001influential reference
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Empirical validation of primary negative symptoms: independence from effects of medication and psychosis.

  1999influential reference
• Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.

  1999cited by this paper
• Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.

  1999influential reference
• Depression in people with first-episode schizophrenia

  1998cited by this paper
• Relations between Neuropsychological Vulnerability Markers and Negative Symptoms in Schizophrenia

  1998cited by this paper
• A review of longitudinal studies of cognitive functions in schizophrenia patients.

  1998cited by this paper
• Revisiting the factor structure for positive and negative symptoms: evidence from a large heterogeneous group of psychiatric patients.

  1997cited by this paper
• Factor structure and construct validity of the Scale for the Assessment of Negative Symptoms

  1996influential reference
• A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.

  1994influential reference
• Positive and negative symptoms in the psychoses: principal components analysis of items from the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms.

  1994influential reference
• Relations between attentional deficits and clinical symptoms in schizophrenic outpatients.

  1993cited by this paper
• Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms.

  1992influential reference
• Schizophrenia, just the facts. What do we know, how well do we know it?

  1988cited by this paper
• The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

  1974cited by this paper

• Animal-assisted therapy in patients with psychotic disorders: a systematic review and meta-analysis.

  2026cites this paper
• Trends and diagnostic challenges in pediatric schizophrenia spectrum disorders in Poland (2014-2019): A nationwide register-based study in an international context.

  2026cites this paper
• Effects of Shared and Nonshared Schizophrenia and Bipolar Disorder Alleles on Cognition and Educational Attainment in the UK Biobank

  2025cites this paper
• Psychosocial Interventions and Functional Recovery in Schizophrenia-Realizing Opportunities Today.

  2025cites this paper
• Cannabis Use and Glutamate across the Psychosis Spectrum: In Vivo Evidence from 7T Proton Magnetic Resonance Spectroscopy

  2025cites this paper
• Formulating Cognitive Functioning to Guide Personalised Treatment for People Diagnosed With Mental Disorders

  2025cites this paper
• The interaction network and potential clinical effectiveness of dimensional psychopathology phenotyping based on EMR: a Bayesian network approach

  2025cites this paper
• Manic symptoms in schizophrenia spectrum disorders

  2025cites this paper
• Clinical practice guidelines for assessment and management of cognitive impairment in schizophrenia

  2025cites this paper
• Dimensions of Psychosis in Delirious and Catatonic Trauma Critically Ill Patients.

  2025cites this paper
• Efficacy of Cortical-Hippocampal Target Intermittent Theta Burst Stimulation (iTBS) on Associative Memory of Schizophrenia: A Double-Blind, Randomized Sham-Controlled Trial

  2024cites this paper
• Epidemiology of bipolar disorder 'with' vs 'without' psychotic features: Distinct subgroups or subjective dichotomy along a continuously distributed, intrinsic symptom domain?

  2024cites this paper
• Biomarker discovery using machine learning in the psychosis spectrum

  2024cites this paper
• The mediating role of psychological flexibility in the relationship between psychotic symptom severity and depression in individuals diagnosed with schizophrenia.

  2024cites this paper
• Psychosis superspectrum II: neurobiology, treatment, and implications

  2024cites this paper
• Loss of normal facial asymmetry in schizophrenia and bipolar disorder: Implications for development of brain asymmetry in psychotic illness.

  2024cites this paper
• Clinical, cognitive, and functional characteristics of recent-onset psychosis with autistic features: A 2-year longitudinal study.

  2024cites this paper
• Transdiagnostic modeling of clinician-rated symptoms in affective and nonaffective psychotic disorders.

  2024cites this paper
• Gender Differences in Cognitive Function of Schizophrenia Patients

  2024cites this paper
• Cognitive performance and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - 2

  2024cites this paper
• Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

  2023cites this paper
• Psychopathological networks in psychosis: Changes over time and clinical relevance. A long-term cohort study of first-episode psychosis.

  2023cites this paper
• Autobiographical memory and the self on the psychosis continuum: investigating their relationship with positive- and negative-like symptoms

  2023cites this paper
• Applying the Project ECHO Model to Support Implementation and Sustainment of Cognitive Behavioral Therapy for Psychosis

  2023cites this paper
• The schizophrenia syndrome, circa 2024: What we know and how that informs its nature.

  2023cites this paper
• Duration of the psychosis prodrome and its relationship to duration of untreated psychosis across all 12 DSM-IV psychotic diagnoses: Evidence for a trans-diagnostic process associated with resilience.

  2023cites this paper
• Implementation of cognitive reappraisal in subthreshold psychosis

  2023cites this paper
• From operational diagnostic to dimensional-continuum concepts of psychotic and non-psychotic illness: Embracing catatonia across psychopathology and intrinsic movement disorder in neural network dysfunction.

  2022cites this paper
• Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies.

  2022cites this paper
• Dysregulation of Long Intergenic Non-Coding RNA Expression in the Schizophrenia Brain

  2022cites this paper
• The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting

  2022influential citation
• Agreement on the contours of schizophrenia: The first order of business.

  2022cites this paper
• The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study.

  2022cites this paper
• Different patterns of white matter microstructural alterations between psychotic and non-psychotic bipolar disorder

  2022cites this paper
• COGNITIVE IMPAIRMENT IN PSYCHOSIS LANDSCAPE REPORT

  2022cites this paper
• Diagnostic Dilemma and Management Difficulties in a Young Patient With Psychosis and Benign Chorea: A Case Report and Review of the Literature

  2022cites this paper
• Spiritual emergence(y), psychosis, and personality: Investigating the role of schizotypy.

  2022cites this paper
• Medical Mimics of Psychiatric Illnesses

  2021cites this paper
• SET-UP MADNESS: A REVIEW

  2021cites this paper
• Alternative Diagnostic Models of the Psychotic Disorders: Evidence-Based Choices

  2021cites this paper
• Differential diagnosis on the autism spectrum: Theorizing an “Ordinary Autism”

  2021cites this paper
• Grey and white matter associations of psychotic-like experiences in a general population sample (UK Biobank)

  2021cites this paper
• Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale

  2021cites this paper
• Subjective Cognitive Complaints in Unaffected First-Degree Relatives of Schizophrenia Patients: Relation to Cognitive Performance, Psychotic Experiences, and Social Functioning

  2021cites this paper
• Sequential Multiple-Assignment Randomized Trials to Compare Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design schizophrenia patient

  2021cites this paper
• Predicting Long-Term Outcomes in First-Admission Psychosis: Does the Hierarchical Taxonomy of Psychopathology Aid DSM in Prognostication?

  2021cites this paper
• The nature of schizophrenia: As broad as it is long.

  2021cites this paper
• Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

  2021cites this paper
• Developments in the Rorschach Assessment of Disordered Thinking and Communication

  2021cites this paper
• Hallucinations and Delusions as Low-Quality Attributions: Influencing Factors and Proposal for Their Analysis

  2021cites this paper
• Schizophrenia: A view of immediate future

  2021cites this paper
• A retrospective naturalistic study on the psychopharmacological treatment of schizoaffective disorder

  2021cites this paper
• Schizophrenia in ICD-11: Comparison of ICD-10 and DSM-5.

  2020cites this paper
• Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.

  2020cites this paper
• Cognición en la esquizofrenia. Estado actual de la cuestión (I): métodos de evaluación y correlatos neurales

  2020cites this paper
• Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.

  2020cites this paper
• Clinical Features of Psychotic Disorders: Comparing Categorical and Dimensional Models

  2020cites this paper
• Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia

  2020influential citation
• A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia

  2020cites this paper
• Mapping brain-behavior space relationships along the psychosis spectrum

  2020influential citation
• Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum

  2020cites this paper
• Clinique différentielle du spectre de l’autisme : l’intérêt de penser un « autisme ordinaire »

  2020cites this paper
• Dimensional Assessment of Emotional Disorder Outcomes in Transdiagnostic Treatment: A Clinical Case Study

  2020cites this paper
• Measurement based care in schizophrenia-Feasibility in routine clinical practice.

  2020cites this paper
• Latent Clinical-Anatomical Dimensions of Schizophrenia

  2020cites this paper
• Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders.

  2020cites this paper
• Schizophrenia in ICD-11: Comparison of ICD-10 and DSM-5

  2020cites this paper
• What Is Psychosis?

  2020cites this paper
• Effectiveness analysis of antipsychotics in schizophrenia using psychometric scales: an observational study

  2020cites this paper
• The role of nicotinic cholinergic neurotransmission in delusional thinking

  2020cites this paper
• Peripheral Blood Leukocyte RNA-Seq Identifies a Set of Genes Related to Abnormal Psychomotor Behavior Characteristics in Patients with Schizophrenia

  2020cites this paper
• Psychometric properties of the DSM-5 Clinician-Rated Dimensions of Psychosis Symptom Severity.

  2019cites this paper
• Efficacy of a combined intervention program for the reduction of internalized stigma in people with severe mental illness.

  2019cites this paper
• Development of a Self-Administered Questionnaire to Detect Psychosis at High Altitude: The HAPSY Questionnaire

  2019cites this paper
• Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode Psychosis.

  2019cites this paper
• Fostering Well-being: Spirituality and Creativity in Clinical Practice

  2019cites this paper
• Cognitive performance and clinical features in adults with vulnerability to psychosis

  2019cites this paper
• Establishing the cut-off score for aggression on the Brief Psychiatric Rating Scale-Excited Component (BPRS-EC) in schizophrenia patients

  2019influential citation
• Altered Functional Connectivity of the Default Mode Network in Patients With Schizo-obsessive Comorbidity: A Comparison Between Schizophrenia and Obsessive-compulsive Disorder

  2019cites this paper
• The Cavan-Monaghan First Episode Psychosis Study (CAMFEPS): arbitrary diagnostic boundaries across the gene–environment interface and within evolving models of care

  2019cites this paper
• The development of Kraepelin’s mature diagnostic concept of hebephrenia: a close reading of relevant texts of Hecker, Daraszkiewicz, and Kraepelin

  2019cites this paper
• Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.

  2019cites this paper
• Évolution de la symptomatologie négative chez les patients schizophrènes hospitalisés

  2019cites this paper
• Psychotic Signs and Symptoms

  2019cites this paper
• Psychosis and Schizophrenia-Spectrum Personality Disorders Require Early Detection on Different Symptom Dimensions

  2019cites this paper
• The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter.

  2019cites this paper
• Temporal Self, Psychopathology, and Adaptive Functioning Deficits: An Examination of Acute Psychiatric Patients

  2019cites this paper
• The evidence‐based group‐level symptom‐reduction model as the organizing principle for mental health care: time for change?

  2019cites this paper
• Bases épistémologiques de la recherche sur les psychoses. Quelle solution pour le choc des paradigmes?

  2019cites this paper
• Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP

  2019cites this paper
• Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan–Monaghan First Episode Psychosis Study (CAMFEPS)

  2019cites this paper
• The Ethical and Empirical Status of Dimensional Diagnosis: Implications for Public Mental Health?

  2018cites this paper
• European Psychiatric/Mental Health Nursing in the 21st Century

  2018cites this paper
• Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6‐year follow‐up of the Cavan‐Monaghan First Episode Psychosis Study (CAMFEPS)

  2018cites this paper
• The Neurobiological Correlates of Psychotic-like Experiences in a Community Sample Provide Insights Into the Structure of Psychotic Disorders.

  2018cites this paper
• The Use of Electroconvulsive Therapy in Late-Life Psychiatric Disorders

  2018cites this paper
• Isolated psychosis during exposure to very high and extreme altitude – characterisation of a new medical entity

  2018cites this paper
• Psychotropic drug-prescribing correlates of disorganized speech in Asians with schizophrenia: The REAP-AP study

  2018cites this paper
• What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors

  2018cites this paper
• Psychotic Disorders Due to Traumatic Brain Injury (PD-TBI)

  2018cites this paper